Finding of hallucinogen in blood
ICD-10 R78.3 is a billable code used to indicate a diagnosis of finding of hallucinogen in blood.
The ICD-10 code R78.3 is used to indicate the presence of hallucinogens in the blood, which can be detected through various toxicology screenings. Hallucinogens are substances that alter perception, mood, and various cognitive processes. Common hallucinogens include LSD, psilocybin (magic mushrooms), and mescaline. The detection of these substances in the bloodstream can be indicative of substance use disorders, acute intoxication, or potential overdose. Symptoms associated with hallucinogen use may include visual or auditory hallucinations, altered sense of time, and significant changes in mood or behavior. Clinicians must consider the patient's history, presenting symptoms, and any co-occurring conditions when interpreting lab results. Accurate documentation of the clinical context surrounding the finding is crucial for appropriate coding and treatment planning.
Detailed patient history, including substance use history and presenting symptoms.
Patients presenting with altered mental status or psychosis potentially related to hallucinogen use.
Consideration of comorbid psychiatric conditions and their impact on treatment.
Acute care documentation including vital signs, mental status examination, and lab results.
Patients presenting with acute intoxication or overdose symptoms.
Rapid assessment and intervention are critical; documentation must reflect urgency and clinical findings.
Used when performing a definitive drug test that includes hallucinogens.
Document the specific substances tested and the clinical rationale for testing.
Ensure that the testing aligns with the clinical presentation and history.
Finding hallucinogens in blood indicates recent use and can help guide treatment decisions, especially in emergency settings. It is crucial for understanding the patient's mental state and potential risks.
